Thornburg Investment Management Inc. Purchases 364,471 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Thornburg Investment Management Inc. raised its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 48.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,122,098 shares of the company's stock after purchasing an additional 364,471 shares during the quarter. Thornburg Investment Management Inc. owned 0.37% of Stevanato Group worth $24,451,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of STVN. TimesSquare Capital Management LLC increased its holdings in Stevanato Group by 114.6% in the fourth quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock valued at $71,657,000 after buying an additional 1,756,100 shares during the last quarter. Jennison Associates LLC bought a new stake in Stevanato Group during the fourth quarter valued at $20,239,000. Frontier Capital Management Co. LLC lifted its position in shares of Stevanato Group by 1,012.0% in the 4th quarter. Frontier Capital Management Co. LLC now owns 1,003,235 shares of the company's stock worth $21,860,000 after buying an additional 913,019 shares during the last quarter. Mutual of America Capital Management LLC bought a new stake in shares of Stevanato Group during the 4th quarter valued at about $13,848,000. Finally, Ranger Investment Management L.P. bought a new position in Stevanato Group in the fourth quarter worth about $12,940,000.

Stevanato Group Stock Down 0.8%

STVN traded down €0.17 ($0.19) during trading on Friday, reaching €22.44 ($25.21). 57,057 shares of the stock traded hands, compared to its average volume of 342,471. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($18.61) and a fifty-two week high of €25.75 ($28.93). The stock's 50-day simple moving average is €21.71 and its two-hundred day simple moving average is €21.31. The stock has a market cap of $6.80 billion, a price-to-earnings ratio of 47.74, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, meeting the consensus estimate of €0.20 ($0.22). The firm had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, equities research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Stevanato Group Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be issued a dividend of $0.0613 per share. This is a positive change from Stevanato Group's previous annual dividend of $0.05. This represents a yield of 0.3%. The ex-dividend date of this dividend is Thursday, June 5th. Stevanato Group's dividend payout ratio (DPR) is 11.76%.

Wall Street Analysts Forecast Growth

STVN has been the topic of a number of research reports. UBS Group dropped their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Finally, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($28.88).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.